MontalbanXLebrun-FrénayCOhJ, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol2025; 24(10): 850–865.
2.
ZürrerWECannonAEIlchenkoD, et al. Misdiagnosis and underdiagnosis of multiple sclerosis: A systematic review and meta-analysis. Mult Scler2024; 30(11–12): 1409–1422.
3.
SolomonAJArrambideGBrownleeWJ, et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol2023; 22: 750–768.
4.
SinneckerTClarkeMAMeierD, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol2019; 76: 1446–1456.
5.
HemondCCDundamadappaSKDeshpandeM, et al. Paramagnetic rim lesions are highly specific for multiple sclerosis in real-world data. Brain Commun2025; 7: fcaf211.
6.
HemondCCSolomonAJ.Multiple Sclerosis can be diagnosed solely with dissemination in space: No. Mult Scler J2024; 30: 639–641.
7.
SolomonAJArrambideGBrownleeW, et al. Confirming a historical diagnosis of multiple sclerosis: challenges and recommendations. Neurol Clin Pract2022; 12(3): 263–269.
8.
TrewinBPBrilotFReddelSW, et al. MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally. Autoimmun Rev2025; 24: 103693.
9.
SolomonAJMarrieRAViswanathanS, et al. Global barriers to the diagnosis of multiple sclerosis: data from the multiple sclerosis international federation Atlas of MS, Third Edition. Neurology2023; 101: e624–e635.
10.
SolomonAJKaiseyMKriegerSC, et al. Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States. Mult Scler2022; 28(8): 1248–1256.
